Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of one of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of gastrointestinal inflammatory disease through their immune-modulating properties. A special emphasis will be placed on the critical role of the anti-inflammatory cytokine IL-10, and a brief overview of the uses of genetically engineered LAB that produce this important immune response mediator will also be discussed. Thus, this paper will demonstrate the critical role that IL...
Inflammatory bowel disease (IBD) generally comprises Crohn's disease (CD) and ulcerative colitis (UC...
Background: Oral treatment with Lactococcus (L.) lactis strains secreting the anti-inflammatory cyto...
Lactobacillus reuteri CRL1101 was found to reduce inflammatory and oxidative damage during endotoxic...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that have been shown to...
Inflammatory bowel diseases (IBDs) affect the gastrointestinal tract and are characterized by recurr...
Intestinal infections are the most common diseases in humans. These infections account for high morb...
Lactobacillus genus includes both probiotic and representative strains of the human gut microbiota. ...
Background: Inflammatory bowel diseases (IBD) are intestinal disorders characterized by inflammation...
We analyzed the gut immune stimulation induced by Gram-positive bacteria: non probiotic Lactobacillu...
Inflammatory Bowel Diseases or IBD affect the gastrointestinal tract and are characterized by recurr...
Inflammatory bowel disease (IBD) generally comprises Crohn's disease (CD) and ulcerative colitis (UC...
Background: Oral treatment with Lactococcus (L.) lactis strains secreting the anti-inflammatory cyto...
Lactobacillus reuteri CRL1101 was found to reduce inflammatory and oxidative damage during endotoxic...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally pres...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Inflammatory Bowel Diseases (IBD) are disorders of the gastrointestinal tract characterized by recur...
Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that have been shown to...
Inflammatory bowel diseases (IBDs) affect the gastrointestinal tract and are characterized by recurr...
Intestinal infections are the most common diseases in humans. These infections account for high morb...
Lactobacillus genus includes both probiotic and representative strains of the human gut microbiota. ...
Background: Inflammatory bowel diseases (IBD) are intestinal disorders characterized by inflammation...
We analyzed the gut immune stimulation induced by Gram-positive bacteria: non probiotic Lactobacillu...
Inflammatory Bowel Diseases or IBD affect the gastrointestinal tract and are characterized by recurr...
Inflammatory bowel disease (IBD) generally comprises Crohn's disease (CD) and ulcerative colitis (UC...
Background: Oral treatment with Lactococcus (L.) lactis strains secreting the anti-inflammatory cyto...
Lactobacillus reuteri CRL1101 was found to reduce inflammatory and oxidative damage during endotoxic...